Atria Investments Inc Purchases Shares of 7,933 Perrigo Company plc (NYSE:PRGO)

Atria Investments Inc purchased a new stake in Perrigo Company plc (NYSE:PRGO) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 7,933 shares of the company’s stock, valued at approximately $208,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Beach Investment Counsel Inc. PA acquired a new position in Perrigo in the second quarter valued at approximately $72,000. Voisard Asset Management Group Inc. increased its holdings in shares of Perrigo by 520.0% during the second quarter. Voisard Asset Management Group Inc. now owns 4,650 shares of the company’s stock valued at $119,000 after acquiring an additional 3,900 shares in the last quarter. CWM LLC increased its holdings in shares of Perrigo by 877.0% during the second quarter. CWM LLC now owns 8,197 shares of the company’s stock valued at $210,000 after acquiring an additional 7,358 shares in the last quarter. Sanctuary Advisors LLC bought a new stake in shares of Perrigo during the second quarter valued at approximately $213,000. Finally, nVerses Capital LLC bought a new stake in shares of Perrigo during the third quarter valued at approximately $262,000. 95.91% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Perrigo news, Director Katherine C. Doyle sold 8,954 shares of the business’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $27.30, for a total value of $244,444.20. Following the transaction, the director now owns 6,009 shares of the company’s stock, valued at approximately $164,045.70. The trade was a 59.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.70% of the company’s stock.

Perrigo Trading Up 3.7 %

Shares of Perrigo stock opened at $28.07 on Monday. The stock has a fifty day simple moving average of $25.98 and a 200 day simple moving average of $27.08. Perrigo Company plc has a 12-month low of $23.89 and a 12-month high of $34.60. The company has a market capitalization of $3.83 billion, a P/E ratio of -23.99 and a beta of 0.48. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.81 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.81. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.12 billion. During the same quarter in the prior year, the company posted $0.64 earnings per share. Perrigo’s revenue was down 3.2% compared to the same quarter last year. On average, sell-side analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Friday, November 29th will be given a $0.276 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.10 annualized dividend and a yield of 3.93%. Perrigo’s dividend payout ratio is currently -94.02%.

Wall Street Analyst Weigh In

PRGO has been the subject of several recent research reports. Jefferies Financial Group restated a “hold” rating and set a $30.00 price objective (down previously from $50.00) on shares of Perrigo in a report on Monday, September 23rd. Canaccord Genuity Group restated a “buy” rating and set a $42.00 price objective on shares of Perrigo in a report on Monday, September 30th. Finally, StockNews.com upgraded Perrigo from a “hold” rating to a “buy” rating in a report on Thursday, November 7th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $37.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.